Altered ex vivo balance between CD28+ and CD28- cells within HIV-specific CD8+ T cells of HIV-seropositive patients

European Journal of Immunology

Volumn 29, Issue 1, 1999, Pages 38-44

  Dalod, Marc ^a,b   Sinet, Martine ^a   Deschemin, Jean Christophe ^a   Fiorentino, Susana ^a   Venet, Alain ^a   Guillet, Jean Gérard ^a  

^a INSTITUT COCHIN   (France)

^b Université Paris Descartes   (France)

Author keywords

CD28; CD8; Epstein Barr virus; HIV 1; IFN

Indexed keywords

CD28 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; EPSTEIN BARR VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA VIRUS; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD28; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES; HERPESVIRUS 4, HUMAN; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; ORTHOMYXOVIRIDAE; T-LYMPHOCYTE SUBSETS;

EID: 0032897559     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199901)29:01<38::AID-IMMU38>3.0.CO;2-2     Document Type: Article

References (14)

1. + T lymphocytes during HIV-1 infection. J. Acquir. Immun. Defic. Syndr. 1994. 7: 245-253.
2. + CD28 cells. AIDS 1996. 10: 104-106.
3. + CD28 lymphocytes in human immunodeficiency virus-specific cytotoxic activity. J. Virol. 1996. 70: 2022-2026.
4. Bouscarat, F., Levacher-Clergeot, M., Dazza, M.-C., Strauss, K. W., Girard, P.-M., Ruggeri, C. and Sinet, M., Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. AIDS 1996. 12: 17-24.
5. + lymphocyte homeostasis during the natural course of HIV-1 infection. J. Clin. Invest. 1998. 101: 137-144.
6. Brinchman, J. E., Dobloug, J. H., Heger, B. H., Haaheim, L. L., Sannes, M. and Egeland, T., Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations. J. Infect. Dis. 1994. 169: 730-738.
7. + T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin. Immunol. Immunopathol. 1993. 69: 106-116.
8. + cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996. 10: F17-F22.
9. + CD28 T cell subsets in HIV type 1-infected individuals. Eur. J. Immunol. 1998. 28: 1738-1742.
10. + T cells during the primary immune response to Epstein-Barr Virus in vivo. J. Exp. Med. 1998. 187: 1395-1402.
11. + T cell clones during primary HIV infection. Proc. Natl. Acad. Sci. USA 1997. 94: 9848-9856.
12. Angel, J. B., Kumar, K., Filion, L. G., Diaz-Mitoma, F., Daftarian, P., Pham, B., Sun, E., Leonard, J. M. and Cameron, D. W., Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir. J. Infect. Dis. 1998. 177: 898-904.
13. + lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy. AIDS 1998. 12: 1267-1273.
14. + T cells. J. Immunol. 1997. 158: 1551-1558.